Sociodemographic Characteristics of Infants Receiving Nirsevimab
This cohort study investigates inequalities by sociodemographic group in the receipt of nirsevimab immunization by infants in France from 2023 to 2024.
Authors
- Marie-Joëlle Jabagi (ORCID: https://orcid.org/0000-0002-7946-7759)
- Martin Chalumeau (ORCID: https://orcid.org/0000-0001-8175-3706)
- Marion Bertrand (ORCID: https://orcid.org/0000-0002-4115-7093)
- Sébastien Boutin (ORCID: https://orcid.org/0000-0002-0499-2460)
- Jérémie F. Cohen (ORCID: https://orcid.org/0000-0003-3572-8985)
- Mahmoud Zureik (ORCID: https://orcid.org/0000-0002-8393-4217)
Institutions
- Hôpital Necker-Enfants Malades (FR)
- Université Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (FR)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.4341
- Citations
- 5
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.99